These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 9627078)

  • 1. Vascular endothelial growth factor upregulates constitutive cyclooxygenase 1 in primary bovine and human endothelial cells.
    Bryant CE; Appleton I; Mitchell JA
    Life Sci; 1998; 62(24):2195-201. PubMed ID: 9627078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective inhibition of vascular endothelial growth factor-mediated angiogenesis by cyclosporin A: roles of the nuclear factor of activated T cells and cyclooxygenase 2.
    Hernández GL; Volpert OV; Iñiguez MA; Lorenzo E; Martínez-Martínez S; Grau R; Fresno M; Redondo JM
    J Exp Med; 2001 Mar; 193(5):607-20. PubMed ID: 11238591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential involvement of the cyclooxygenase-2 pathway in the regulation of tumor-associated angiogenesis and growth in pancreatic cancer.
    Chu J; Lloyd FL; Trifan OC; Knapp B; Rizzo MT
    Mol Cancer Ther; 2003 Jan; 2(1):1-7. PubMed ID: 12533667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sustained pulsatile flow regulates endothelial nitric oxide synthase and cyclooxygenase expression in co-cultured vascular endothelial and smooth muscle cells.
    Hendrickson RJ; Cappadona C; Yankah EN; Sitzmann JV; Cahill PA; Redmond EM
    J Mol Cell Cardiol; 1999 Mar; 31(3):619-29. PubMed ID: 10198192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Upregulation of angiotensin-converting enzyme by vascular endothelial growth factor.
    Saijonmaa O; Nyman T; Kosonen R; Fyhrquist F
    Am J Physiol Heart Circ Physiol; 2001 Feb; 280(2):H885-91. PubMed ID: 11158990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The expression of COX-2 in VEGF-treated endothelial cells is mediated through protein tyrosine kinase.
    Akarasereenont PC; Techatraisak K; Thaworn A; Chotewuttakorn S
    Mediators Inflamm; 2002 Feb; 11(1):17-22. PubMed ID: 11926591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term fenofibrate treatment impairs endothelium-dependent dilation to acetylcholine by altering the cyclooxygenase pathway.
    Blanco-Rivero J; Márquez-Rodas I; Xavier FE; Aras-López R; Arroyo-Villa I; Ferrer M; Balfagón G
    Cardiovasc Res; 2007 Jul; 75(2):398-407. PubMed ID: 17412316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Upregulation of vascular endothelial growth factor by cobalt chloride-simulated hypoxia is mediated by persistent induction of cyclooxygenase-2 in a metastatic human prostate cancer cell line.
    Liu XH; Kirschenbaum A; Yao S; Stearns ME; Holland JF; Claffey K; Levine AC
    Clin Exp Metastasis; 1999; 17(8):687-94. PubMed ID: 10919714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nitric oxide synthase-inhibition hypertension is associated with altered endothelial cyclooxygenase function.
    Bratz IN; Kanagy NL
    Am J Physiol Heart Circ Physiol; 2004 Dec; 287(6):H2394-401. PubMed ID: 15319202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meconium aspiration stimulates cyclooxygenase-2 and nitric oxide synthase-2 expression in rat lungs.
    Kytölä J; Kääpä P; Uotila P
    Pediatr Res; 2003 May; 53(5):731-6. PubMed ID: 12621123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostaglandin E2 induces hypoxia-inducible factor-1alpha stabilization and nuclear localization in a human prostate cancer cell line.
    Liu XH; Kirschenbaum A; Lu M; Yao S; Dosoretz A; Holland JF; Levine AC
    J Biol Chem; 2002 Dec; 277(51):50081-6. PubMed ID: 12401798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular endothelial growth factor induces cyclooxygenase-dependent proliferation of endothelial cells via the VEGF-2 receptor.
    Murphy JF; Fitzgerald DJ
    FASEB J; 2001 Jul; 15(9):1667-9. PubMed ID: 11427521
    [No Abstract]   [Full Text] [Related]  

  • 13. Cyclooxygenase-2-mediated angiogenesis in carrageenin-induced granulation tissue in rats.
    Ghosh AK; Hirasawa N; Niki H; Ohuchi K
    J Pharmacol Exp Ther; 2000 Nov; 295(2):802-9. PubMed ID: 11046121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclooxygenase inhibitors suppress angiogenesis and reduce tumor growth in vivo.
    Sawaoka H; Tsuji S; Tsujii M; Gunawan ES; Sasaki Y; Kawano S; Hori M
    Lab Invest; 1999 Dec; 79(12):1469-77. PubMed ID: 10616198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular endothelial growth factor up-regulates cyclooxygenase-2 expression in human endothelial cells.
    Tamura M; Sebastian S; Gurates B; Yang S; Fang Z; Bulun SE
    J Clin Endocrinol Metab; 2002 Jul; 87(7):3504-7. PubMed ID: 12107271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of nitric oxide, prostaglandins and tyrosine kinase in vascular endothelial growth factor-induced increase in vascular permeability in mouse skin.
    Fujii E; Irie K; Ohba K; Ogawa A; Yoshioka T; Yamakawa M; Muraki T
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Oct; 356(4):475-80. PubMed ID: 9349634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PGE(2) is generated by specific COX-2 activity and increases VEGF production in COX-2-expressing human pancreatic cancer cells.
    Eibl G; Bruemmer D; Okada Y; Duffy JP; Law RE; Reber HA; Hines OJ
    Biochem Biophys Res Commun; 2003 Jul; 306(4):887-97. PubMed ID: 12821125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nitric oxide mediates the mitogenic effects of insulin and vascular endothelial growth factor but not of leptin in endothelial cells.
    Józkowicz A; Pankiewicz J; Dulak J; Partyka L; Wybrańska I; Huk I; Dembińska-Kieć A
    Acta Biochim Pol; 1999; 46(3):703-15. PubMed ID: 10698278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of aminoguanidine and cyclooxygenase inhibitors on nitric oxide and prostaglandin production, and nitric oxide synthase and cyclooxygenase expression induced by lipopolysaccharide in the estrogenized rat uterus.
    Ribeiro M; Cella M; Farina M; Franchi A
    Neuroimmunomodulation; 2004; 11(3):191-8. PubMed ID: 15067210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of cyclooxygenase-derived prostaglandin E2 and nitric oxide in the protection of rat pancreas afforded by low dose of lipopolysaccharide.
    Jaworek J; Bonior J; Tomaszewska R; Jachimczak B; Kot M; Bielański W; Pawlik WW; Sendur R; Stachura J; Konturek PC; Konturek SJ
    J Physiol Pharmacol; 2001 Mar; 52(1):107-26. PubMed ID: 11321505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.